Diabetes is a chronic disease that makes controlling blood sugar levels challenging. For many individuals, the problem gets worse with time, making blood sugar management more challenging. Semaglutide is one example of GLP-1 receptor agonist that has provided patients with better control ove
Diabetes is a chronic condition that makes it difficult to regulate blood sugar levels. For many people, the condition worsens with time, making it harder to control blood sugar levels. Semaglutide is one example of a GLP-1 receptor agonist that has given patients more control over blood sug
Yashpal Arya requested the Chief Minister not to give Aswani, a subsidiary of Bajpur Sugar Mill, on lease rent or public-private partnership (PPP) mode and also submitted a memorandum in this regard.
"The decision will benefit 5 crore sugarcane farmers and their dependents, as well as 5 lakh workers employed in the sugar mills and related ancillary activities," Anurag Thakur said.
The Uttar Pradesh government headed by Chief Minister Yogi Adityanath has made a record payment of Rs 2.14 lakh crore to sugarcane farmers in the last 6 years.
Diabetes is a chronic condition that affects one's capacity to regulate blood sugar levels. Many patients' conditions worsen over time, making blood sugar levels more difficult to control. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, have given patients greater con
Researchers found people who develop diabetes after pregnancy were significantly less likely to be able to control it if they had gestational diabetes, especially if they were Black or Hispanic.
Researchers discovered that cancer patients had sweet-smelling urine back in the 1920s. The doctors were first perplexed, but they quickly understood that it was caused by high blood sugar levels.
According to a recent study, sugar molecules can be coupled with polyphenolic chemicals, which are frequently present in fruits and vegetables, to produce potentially life-saving medications.
A research presented on Saturday at ENDO 2023, the Endocrine Society's annual conference in Chicago, Ill, said closed-loop insulin administration devices enhance glucose control in kids with type 1 diabetes without having any negative consequences.